Emergency Department Triage of Patients With Acute Chest Pain Based on the ESC 0/1-hour Algorithm (PRESC1SE-MI)
NCT ID: NCT05649384
Last Updated: 2025-06-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
64374 participants
INTERVENTIONAL
2020-12-01
2026-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Currently, most emergency departments worldwide use the 0/3-hour troponin algorithm. Cardiac troponin (cTn) is a heart-specific biomarker which indicates damage of the heart muscle and which increases after a heart attack. In the 0/3-hour algorithm, the amount of troponin in the bloodstream is measured with a high-sensitivity assay at admission and 3 hours thereafter. Likewise, the 0/1-hour algorithm means that the blood sample in which the troponin is measured is collected at admission and 1 hour later. Since recent clinical studies suggest that the 0/1-hour algorithm is superior to the 0/3-hour algorithm, many hospitals consider switching to the 0/1-hour algorithm.
The aim of this study is to assess how feasible the time-saving 0/1-hour algorithm would be in reality and whether it provides the same accuracy and safety in the diagnosis of myocardial infarction as the current practice the 0/3-hour algorithm.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Rapid Use of High-sensitive Cardiac Troponin I for ruling-in and Ruling-out of Acute Myocardial Infarction
NCT03634384
Pragmatic Randomised Trial of the ESC 0/1 Versus 0/3 Hour Troponin Pathway
NCT05322395
Early Risk Stratification in ED Chest Pain Patients
NCT02364271
Feasibility and Security of a Rapid Rule-out and rule-in Troponin Protocol in the Management of NSTEMI in an Emergency Departement
NCT03668587
High-Sensitivity Cardiac Troponin On Presentation to Rule Out Myocardial Infarction
NCT03005158
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
0/1-hour algorithm
High-sensitivity cardiac troponin (hs-cTn) blood tests are performed at admission (0 h) and 1 hour later in the emergency department.
European Society of Cardiology hs-cTnT/I 0 h/1 h algorithm
High-sensitivity cardiac troponin (hs-cTn) blood tests are performed at admission (0 h) and 1 hour later in the emergency department.
0/3-hour algorithm
High-sensitivity cardiac troponin (hs-cTn) blood tests are performed at admission (0 h) and 3 hours later in the emergency department.
European Society of Cardiology hs-cTnT/I 0 h/3 h algorithm
High-sensitivity cardiac troponin (hs-cTn) blood tests are performed at admission (0 h) and 3 hours later in the emergency department.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
European Society of Cardiology hs-cTnT/I 0 h/1 h algorithm
High-sensitivity cardiac troponin (hs-cTn) blood tests are performed at admission (0 h) and 1 hour later in the emergency department.
European Society of Cardiology hs-cTnT/I 0 h/3 h algorithm
High-sensitivity cardiac troponin (hs-cTn) blood tests are performed at admission (0 h) and 3 hours later in the emergency department.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Presentation with acute non-traumatic acute chest pain to the emergency department
* Suspicion of acute myocardial infarction
Exclusion Criteria
* Cardiac arrest
* Cardiogenic shock
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Basel, Switzerland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christian Müller, MD Prof.
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Basel, Switzerland
Jasper Boeddinghaus, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Basel, Switzerland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Baylor St. Luke's Medical Center
Houston, Texas, United States
St Andrew's War Memorial Hospital Brisbane
Brisbane, , Australia
Vienna General Hospital (AKH Wien)
Vienna, , Austria
University Central Hospital Helsinki
Helsinki, , Finland
Attikon General Hospital Athens
Athens, , Greece
Careggi University Hospital Florence
Florence, , Italy
Azienda Ospedaliera San Giovanni Addolorata
Roma, , Italy
Hospital Città della Salute e della Scienza di Torino
Torino, , Italy
Emergency Institute for Cardiovascular Diseases C.C. Iliescu
Bucharest, , Romania
Konkuk University Medical Center
Seoul, , South Korea
Hospital Clinic Barcelona
Barcelona, , Spain
University Hospital October 12 Madrid
Madrid, , Spain
University Hospital Ramon y Cajal
Madrid, , Spain
Hospital Clínico Universitario Valencia
Valencia, , Spain
Kantonsspital Aarau
Aarau, , Switzerland
St. Claraspital
Basel, , Switzerland
Kantonsspital Luzern
Lucerne, , Switzerland
University Hospital Zurich
Zurich, , Switzerland
Royal London Hospital
London, , United Kingdom
Royal Cornwall Hospitals Treliske
Truro, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-02269
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.